LORRAINE STEELMAN: Open Payments
NPI 1386820181 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 7 payments from 5 companies in 2025. Trend: 2023 $349 · 2024 $348 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $314 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| ADMA BioManufacturing LLC | 1 | $91 |
| Grifols USA, LLC | 1 | $83 |
| ABBVIE INC. | 1 | $15 |
Products named: NUCALA, COSELA, Xembify, LINZESS.
Industry payments across TX — which companies pay providers there.
